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Abstract Direct adhesion of Helicobacter pylori to immobilized
glycosphingolipids (GSLs) was compared to that of their
corresponding oligosaccharide-conjugated neoglycoconjugates
in order to clarify the roles of the carbohydrate and lipid
portions of GSLs in H. pylori adhesion. These bacteria were
found to adhere to sulfatide, GM3, GalCer and LacCer, but not
to ceramide, sphingomyelin, or polyacrylamides conjugated with
L-galactose, lactose, 3P-sialyllactose or 3P-sulfo-L-galactose.
Furthermore, neoglycolipids or bovine serum albumin derivatives
with corresponding oligosaccharides were unable to serve as the
ligands. H. pylori adhesion to GalCer with K-hydroxyl fatty acid
was much stronger than GalCer with the non-hydroxyl fatty acid.
These results suggest that H. pylori recognize the conformation
of GSL with K-hydroxyl fatty acid on solid phase. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Recognition of cell surface carbohydrates is essential for the
colonization and initiation of infection by bacteria. Helico-
bacter pylori is thought to be the primary cause of active
chronic gastritis, to be involved in the development of gastric
and duodenal ulcers, and to have a possible association with
gastric cancer [1^4]. Many studies have suggested that one
putative group of receptor molecules for H. pylori consists
of glycosphingolipids1 (GSL) expressed on the epithelial sur-
face of the gastric mucosa, including sulfatide (I3SO3-GalCer)
and GM3 (II3NeuAc-LacCer) [5^7]. However, it remains un-
clear whether H. pylori recognize only the carbohydrate por-
tion of GSL or whether both carbohydrate and lipid portions
are required for recognition of GSL by H. pylori. In addition,
there is only limited information regarding the e¡ect of the
glycoform in the adhesion of H. pylori.
For a better understanding of H. pylori adhesion to GSLs,
in the present study, direct adhesion of these bacteria to im-
mobilized GSLs was compared with that to neoglycolipids,
neoglycoproteins, and oligosaccharide-conjugated polyacryl-
amides (PAAs) with oligosaccharide moieties corresponding
to those of the GSLs.
2. Materials and methods
2.1. Materials
Sulfatide, GM3, GalCer, LacCer, sphingomyelin, ceramide from
bovine brain and lactose-BSA (bovine serum albumin) were purchased
from Sigma-Aldrich (Tokyo, Japan). 3P-Sialyllactose-BSA was from
Funakoshi (Tokyo, Japan). GalCer and ceramide with K-hydroxyl
fatty acid and GalCer and ceramide with non-hydroxyl fatty acid
were also obtained from Sigma-Aldrich. Neoglycolipids constructed
with dipalmitoylphosphatidylethanolamine (DPPE) and oligosaccha-
rides were synthesized by reductive amination and puri¢ed in our
laboratory, as described previously [8]. The biotin-labeled PAA-con-
jugated oligosaccharides (oligosaccharide-PAA-biotin) [9] were from
Seikagaku Kogyo Co. (Tokyo, Japan) and Syntesome (Munich, Ger-
many). Molecular weight of each oligosaccharide-PAA-biotin probe is
about 30^40 kDa and the carbohydrate content is 20 mol%. Anti-H.
pylori mouse polyclonal antibody was produced by injecting BALB/c
mice with H. pylori strain KH202 as an antigen. Ricinus communis
agglutinin 120 (RCA120) was purchased from Seikagaku Kogyo Co.
2.2. Bacterial strain and growth conditions
H. pylori strain KH202, which is a clinical isolate from a patient
with gastritis, was obtained from Amagasaki Hospital, and main-
tained in the Central Research Laboratories of Kaken Pharmaceutical
Co., Ltd. (Kyoto, Japan). H. pylori KH202 was cultured on brain^
heart infusion agar with de¢brinated horse blood (7% v/v) under
microaerophilic conditions at 37‡C for 3 days. Subsequently, the bac-
teria were transferred to a liquid medium of brucella broth (Difco)
containing 7% fetal calf serum and kept under microaerophilic con-
ditions at 37‡C for 24 h. A bacterial suspension with an absorbance of
about 0.5 at 540 nm was used for the experiments.
2.3. Immobilization of glycoconjugates
GSLs and neoglycolipids were dissolved in methanol at a concen-
tration of 0.1 mg/ml. Each solution (50 Wl) was placed in wells of a 96-
well microtiter plate and dried overnight at 37‡C. For immobilization
of neoglycoproteins, a solution of these glycoconjugates was placed in
wells of a 96-well microtiter plate and kept overnight at 4‡C. The
wells were washed thoroughly with phosphate-bu¡ered saline (PBS)
and then blocked with PBS containing 3% BSA. For immobilization
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of oligosaccharide-PAA-biotin, wells of a 96-well plate were ¢rst
coated with 50 Wl of streptavidin (50 Wg/ml), washed thoroughly
with PBS, and then treated with 50 Wl of the oligosaccharide-PAA-
biotin probes. After a 1-h incubation, the wells were washed, and the
excess of streptavidin coated on the wells was masked with 0.1 mg/ml
of biotin at room temperature for 1 h, followed by blocking with 3%
BSA in PBS. Immobilization of GSLs, neoglycolipids, neoglycopro-
teins, and oligosaccharide-PAA-biotin probes was determined by the
binding of peroxidase-conjugated lectins, e.g. RCA120, followed by
visualization with 0.1% H2O2 and 2,2P-azino-di-[3-ethylbenzthianozo-
line-6-sulfonic acid]. The absorbance at 415 nm was determined using
a Model 450 Microplate Reader (Bio-Rad Laboratories, Hercules,
CA, USA). As shown in Fig. 1, LacCer, lactose-DPPE, lactose-
PAA, and lactose-BSA were immobilized on wells in a concentra-
tion-dependent manner in accordance with these procedures. It should
be noted that the wells coated with LacCer, lactose-DPPE, and lac-
tose-PAA exhibited similar absorbance at 415 nm when the same
concentration of glycoconjugates was added and immobilized in wells,
indicating that almost the same quantities of lactose residues are
present in these coated wells. These results suggest that equivalent
quantities of the oligosaccharide residues were immobilized when oth-
er GSLs, neoglycolipids, and PAA-biotin probes were used, although
the actual quantities of the other oligosaccharide residues in wells
were not determined.
2.4. Direct adhesion of H. pylori
Each assay was performed in triplicate at least twice. The suspen-
sion (100 Wl) of H. pylori was added to the wells of a 96-well plate
coated with glycoconjugates, and the plate was incubated in a micro-
aerobic atmosphere at 37‡C for 90 min. After incubation, non-adher-
ent bacteria were removed by washing with PBS and the wells were
allowed to react with mouse anti-H. pylori antiserum in PBS contain-
ing 1% BSA. The plates were then treated at 37‡C for 1 h with per-
oxidase-conjugated goat anti-mouse IgG antibody in PBS containing
1% BSA. After they were washed with PBS containing 0.05% Tween
20, the remaining enzyme activity in the wells was visualized by in-
cubation with 0.1% H2O2 and 2,2P-azino-di-[3-ethylbenzthianozoline-
6-sulfonic acid] at room temperature for 30 min. Absorbance at 415
nm was determined using a Model 450 Microplate Reader (Bio-Rad).
Speci¢c adhesion of H. pylori to the immobilized glycoconjugates was
estimated from di¡erences in absorbance at 415 nm with respect to the
glycoconjugate-coated wells and uncoated wells (for glycolipids and
glycoproteins) or biotin-coated wells (for oligosaccharide-conjugated
PAAs).
3. Results
3.1. Comparison of H. pylori adhesion to GSL and oligosac-
charide-conjugated PAA
It has been shown that H. pylori preferentially recognize
sulfatide (I3SO3-GalCer) and GM3 (II3NeuAc-LacCer) [5^7].
In the direct adhesion assay used in the current research, H.
pylori strain KH202 clearly adhered to the sulfatide and GM3
immobilized on the plates (Fig. 1). However, H. pylori bound
to immobilized GalCer and LacCer much more strongly than
to sulfatide and GM3 (Fig. 2). These results suggest that
GalCer and LacCer serve as better ligands for H. pylori
than sulfatide and GM3, which have both been proposed as
GSL ligands for the bacteria. In order to investigate whether
H. pylori recognized only carbohydrate regions of the GSLs,
the same concentration of PAA-conjugated derivatives with
the corresponding carbohydrate moieties to sulfatide, GM3,
GalCer and LacCer, i.e. 3P-sulfo-L-galactose-PAA, 3P-sialyl-
lactose-PAA, L-galactose-PAA, and lactose-PAA, were added
and immobilized in the plates. The adhesion of H. pylori to
these immobilized oligosaccharides was then compared to that
to the corresponding immobilized GSLs. The quantities of the
immobilized lactose residues of LacCer- and lactose-PAA-
Fig. 1. Immobilization of various glycoconjugates with lactose on
solid phase. 50 Wl of di¡erent concentrations (5, 10, 25, 50, and 100
Wg/ml) of LacCer (F), lactose-PAA (b), lactose-DPPE (a), or lac-
tose-BSA (E) were added to wells of 96-well plates, and immobilized
according to the procedures described in Section 2. After the wells
had been washed and covered with BSA, the remaining lactose resi-
dues on wells were determined with peroxidase-conjugated RCA120
(1 Wg/ml). Absorbance at 415 nm was measured.
Fig. 2. Adhesion of H. pylori to GSL-coated and oligosaccharide-
PAA-coated plates. GalCer, LacCer, GM3 and sulfatide (100 Wg/
ml), as well as biotinylated L-galactoside-PAA, lactose-PAA, 3P-sia-
lyllactose-PAA, and 3P-sulfo-L-galactoside-PAA (100 Wg/ml), were
coated on other wells of the same 96-well plate, as described in Sec-
tion 2. With LacCer and lactose-PAA, the level of immobilization
on wells was determined by RCA120 (A415nm = 2.03 for a LacCer-
coated well and A415nm = 1.96 for a lactose-PAA-coated well). A sus-
pension of H. pylori was added to wells of the 96-well plate coated
with the glycoconjugates, and the plate was incubated in a micro-
aerobic atmosphere at 37‡C for 90 min. The adherent H. pylori
were detected with the anti-H. pylori polyclonal antibody. The spe-
ci¢c adhesion of H. pylori to the immobilized glycoconjugates was
obtained from di¡erences in absorbance with respect to the glyco-
conjugate-coated wells and uncoated (for GSLs, A415nm = 0.07) or bi-
otin-coated wells (for oligosaccharide-PAA, A415nm = 0.086). Bars
represent the means+S.D. of three experiments.
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coated plates were almost equivalent, as determined by the
reactivity of the wells with RCA120 (A415nm = 2.03 for a
LacCer-coated well and A415nm = 1.96 for a lactose-PAA-
coated well ; Fig. 1). H. pylori did not bind to immobilized
lactose-PAA, but did bind to immobilized LacCer (Fig. 2).
The increase in H. pylori binding to the LacCer-coated plate
paralleled the increase in the amounts of immobilized LacCer
(estimated from the reactivity with RCA120 on the coated
plate). However, no binding to the lactose-PAA-coated plate
was observed even when the same quantity of lactose residue
from LacCer was immobilized on a plate (Fig. 3A). Similarly,
the levels of adhesion of H. pylori to GalCer, GM3, and
sulfatide were also dependent on the concentration of GSLs
added to wells, but adhesion of H. pylori to L-galactoside-
PAA, 3P-sialyllactose-PAA, and 3P-sulfo-L-galactoside-PAA
was not observed, even when the concentration of oligosac-
charide-PAA increased (Figs. 2 and 3B). These results indicate
that the lipid portion of GSL is required for adhesion of
H. pylori. In contrast, the recognition speci¢city of the carbo-
hydrate portions in the GSLs seemed to be rather broad.
3.2. Ceramide is essential for recognition of GSLs
The adhesion of H. pylori to GSLs was then compared to
that with neoglycolipids composed of DPPE oligosaccharides
in order to investigate the requirement of a lipid portion for
bacterial adhesion. When the equivalent quantities of lactose-
DPPE and LacCer were coated on wells as lactose
(A415nm = 2.03 for a LacCer-coated well and A415nm = 1.99 for
a lactose-DPPE-coated well ; Fig. 1), H. pylori did not adhere
to lactose-DPPE, whereas they clearly adhered to LacCer
Fig. 3. Adhesion of H. pylori to di¡erent amounts of immobilized
GSLs and oligosaccharide-PAA probes. A: Di¡erent concentrations
(5, 10, 25, 50, and 100 Wg/ml) of LacCer (F) or lactose-PAA (b)
were coated onto wells of two 96-well plates. The level of immobi-
lized LacCer and lactose-PAA were measured as the amount of
L-galactose residues remaining on the wells of one plate (indicated
on the abscissa) using the reactivity of the glycoconjugate-coated
wells with peroxidase-conjugated RCA120. B: Di¡erent concentra-
tions (5, 10, 25, 50, and 100 Wg/ml) of GalCer (F), sulfatide (b),
and GM3 (R), as well as PAA probes containing their correspond-
ing oligosaccharides (respective open symbols), were added to wells
of 96-well plates and coated. A suspension of H. pylori was added
to wells of the 96-well plate coated with the glycoconjugates, and
the plate was incubated in a microaerobic atmosphere at 37‡C for
90 min. The adherent H. pylori were detected with the anti-H. pylori
polyclonal antibody.
Fig. 4. Adhesion of H. pylori to GSL-coated plates and correspond-
ing neoglycolipid- or neoglycoprotein-coated plates. A: GalCer,
LacCer, GM3, lactose-DPPE, 3P-sialyllactose-DPPE and BSA deriv-
atives (100 Wg/ml) were coated on wells of a 96-well plate. The lac-
tose residue remaining on wells coated with LacCer, lactose-DPPE,
and lactose-BSA was determined with peroxidase-conjugated
RCA120 (A415nm = 2.03, 1.99, and 1.38 for LacCer-, lactose-DPPE-,
and lactose-BSA-coated wells, respectively). B: GalCer, ceramide,
sphingomyelin, and phosphatidylcholine (100 Wg/ml) were coated on
wells of a 96-well plate. A suspension of H. pylori was added to
wells of the 96-well plate coated with the glycoconjugates, and the
plate was incubated in a microaerobic atmosphere at 37‡C for 90
min. The adherent H. pylori were detected with the anti-H. pylori
polyclonal antibody. Bars represent the means+S.D. of three experi-
ments.
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(Fig. 4A). They also adhered to an equivalent amount of
GalCer. Notably, lactose-DPPE, LacCer, and GalCer all
have a L-galactoside residue at their non-reducing termini,
but their lipid portions di¡er, i.e. lactose-DPPE has diglycer-
ide as its lipid and GalCer and LacCer have ceramide. In
addition, 3P-sialyllactose-DPPE did not serve as a ligand,
whereas GM3 did (Fig. 4A). Furthermore, lactose-BSA and
3P-sialyllactose-BSA did not serve as ligands, although the
quantities of the immobilized oligosaccharide residues on
BSA-derivative-coated wells were much lower than those of
the corresponding GSL-coated wells (A415nm = 2.03 for a
LacCer-coated well and A415nm = 1.58 for a lactose-BSA-
coated well ; Fig. 1). These results suggest that the ceramide
contained in GSL is essential for adhesion of H. pylori to
glycolipids.
Since all of the GSLs tested in this study served as ligands
for H. pylori, while none of the synthesized neoglycoconju-
gates did, regardless of the carbohydrate portion, we consid-
ered whether ceramide itself acts as the ligand for H. pylori
and whether the carbohydrate portion may be not involved in
the adhesion of H. pylori to GSLs. Therefore, we examined
the adhesion of H. pylori to ceramide and sphingomyelin,
which are sphingolipid derivatives lacking carbohydrates. As
shown in Fig. 4B, the adhesion of H. pylori to sphingomyelin
and ceramide was almost negligible when the same amount of
sphingomyelin, ceramide, and GalCer were immobilized on
the solid phase. These results strongly indicate that carbohy-
drate moieties are also essential for recognition of GSL by
H. pylori, regardless of the carbohydrate structure.
The binding of H. pylori to GalCer with K-hydroxyl fatty
acid was 20-fold higher than to that with non-hydroxyl fatty
acid (Fig. 5). On the other hand, adhesion of the bacteria to
ceramide with or without K-hydroxyl fatty acid is very low.
Although the speci¢c adhesion of ceramide mixture in Fig. 3
is much lower than that of ceramide with or without K-hy-
droxyl fatty acid in Fig. 4, this di¡erence is due to the di¡er-
ence in the background level. When wells were coated with
GalCer in the same quantities, but each well contained di¡er-
ent ratios of the two fatty acid forms, the increase observed in
the adhesion of H. pylori paralleled the concentration of
GalCer with K-hydroxyl fatty acid (Fig. 6). On the other
hand, ceramide with K-hydroxyl fatty acid did not serve as
a ligand for H. pylori. These results suggest that both the
carbohydrate portion and ceramide with K-hydroxyl fatty
acid are essential for H. pylori recognition of GSLs.
4. Discussion
At present, several candidate carbohydrates have been pro-
posed as adhesion receptors for H. pylori based on the inhi-
bition of H. pylori adherence by glycoconjugates. For in-
stance, GM3 and glycoproteins containing the SiaK2-3Gal
structure, such as fetuin, inhibit the adhesion of these bacteria
[5,10,11]. It was also demonstrated that sulfated lactosylcera-
mide (II3SO3-LacCer), sulfatide (I3SO3-GalCer), and several
glycosaminoglycans or sulfated polysaccharides all had the
ability to inhibit H. pylori adhesion [5,7,12^14]. These pre-
vious inhibition studies indicated that H. pylori recognized
glycoconjugates. They also suggested that carbohydrate li-
gands for H. pylori were shared in several glycoforms such
as GSLs, glycoproteins, and glycosaminoglycans, and that
H. pylori appeared to recognize only speci¢c carbohydrate
moieties carried on these glycoconjugates, regardless of the
carrier to which the carbohydrates were bound. However,
Fig. 5. Adhesion of H. pylori to GalCer with K-hydroxyl fatty acid
or non-hydroxyl fatty acid. GalCer with K-hydroxyl fatty acid,
GalCer with non-hydroxyl fatty acid, ceramide with K-hydroxyl
fatty acid, and ceramide with non-hydroxyl fatty acid (100 Wg/ml)
were coated on wells of a 96-well plate, as described in Section 2. A
suspension of H. pylori was added to wells of the 96-well plate
coated with the glycoconjugates, and the plate was incubated in a
microaerobic atmosphere at 37‡C for 90 min. The adherent H. pylo-
ri were detected with the anti-H. pylori polyclonal antibody. Bars
represent the means+S.D. of three experiments.
Fig. 6. Adhesion of H. pylori depends on the density of GalCer
with K-hydroxyl fatty acid. GalCer with K-hydroxyl fatty acid and
GalCer with non-hydroxyl fatty acid were mixed at the appropriate
ratio (indicated in the abscissa) at the ¢nal concentration of 100 Wg/
ml. The ceramide with K-hydroxyl fatty acid and the ceramide with
non-hydroxyl fatty acid were also mixed at the appropriate ratio at
the ¢nal concentration of 100 Wg/ml. Fifty microliters of the mixed
GalCer (b) or ceramide (E) (each 100 Wg/ml) was added in the wells
of a 96-well plate and coated on the wells, as described in Section
2. The suspension of H. pylori was added to the wells of a 96-well
plate coated with glycoconjugates, and the plate was incubated in a
microaerobic atmosphere at 37‡C for 90 min. The adherent H. pylo-
ri were detected with the anti-H. pylori polyclonal.
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no experiment has compared the direct adhesion of H. pylori
with respect to di¡erent types of glycoconjugates with the
same carbohydrate portions using the same conditions at
the same time. Therefore, whether H. pylori recognize only
carbohydrate portions of glycoconjugates or not remains un-
clear. In order to elucidate the e¡ect of the carbohydrate
carrier on recognition of glycoconjugates by H. pylori, direct
adhesion of the bacteria to di¡erent types of glycoconjugates
with the same carbohydrate portion should be compared.
In the present study, we analyzed the direct adhesion of
H. pylori to GSLs and glycoconjugates with the correspond-
ing carbohydrates of GSLs in order to clarify the role of the
lipid portion in recognition of GSLs by H. pylori. The follow-
ing ¢ndings strongly indicate that not only the carbohydrate
portion, but also the ceramide portion, particularly ceramide
with K-hydroxyl fatty acid, is required for recognition of
GSLs by H. pylori, although the recognition of the carbohy-
drate portions in the GSLs seems to be not speci¢c; (1) H.
pylori clearly bound to several immobilized GSLs such as
GalCer, sulfatide, LacCer and GM3, but they did not bind
at all to the corresponding oligosaccharide-PAA probes, neo-
glycolipids, or BSA derivatives, (2) sphingomyelin or ceramide
itself did not serve as a ligand for H. pylori, indicating that
carbohydrate moieties are also essential for adhesion of H.
pylori to GSLs, and (3) GalCer with K-hydroxyl fatty acid
was preferentially recognized by H. pylori rather than that
with non-hydroxyl fatty acid. Therefore, consideration of
the carbohydrate carrier is important in understanding the
speci¢c carbohydrate ligand for H. pylori. In the case of
GSLs, H. pylori may recognize the speci¢c conformation of
GSLs consisting of both carbohydrate portions and ceramide
with K-hydroxyl fatty acid.
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